Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Aevis Victoria SA operates in the healthcare and hospitality sectors, primarily focused on the management of private clinics and luxury hotels. The company owns and manages a network of Swiss private clinics through its subsidiary, Swiss Medical Network, providing a range of medical services. In the hospitality segment, Aevis Victoria has investments in several luxury hotels under its subsidiary, Victoria-Jungfrau Collection, offering upscale accommodation and services in Switzerland. Headquartered in Fribourg, Switzerland, the company benefits from its strategic positioning in high-demand markets, leveraging its expertise to integrate healthcare services with hospitality. Its diverse portfolio across healthcare and luxury accommodations forms the basis of its business model.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Aevis Victoria SAEli Lilly
Last price
CHF 15.03$1,142.85
Currency
CHF
USD
CHF 1.3B$1T
-38.36
-CHF 0.23$29.79
-0.090.50
0$6.69
00.61%
Sector
HealthHealth
Employees
4,87050,000
Ticker
Fr. AEVS$LLY
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.AEVS or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.